HEADER TRANSFERASE/TRANSFERASE INHIBITOR 05-NOV-03 1RDQ TITLE HYDROLYSIS OF ATP IN THE CRYSTAL OF Y204A MUTANT OF CAMP-DEPENDENT TITLE 2 PROTEIN KINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT; COMPND 3 CHAIN: E; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, ALPHA FORM; COMPND 10 CHAIN: I; COMPND 11 FRAGMENT: RESIDUES 5-24; COMPND 12 SYNONYM: PKI-ALPHA, CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 13 MUSCLE/BRAIN ISOFORM; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: PRKACA, PKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: THE PROTEIN WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 11 OF THE PROTEIN IS NATURALLY FOUND IN MUS MUSCULUS (MOUSE) KEYWDS CAMP-DEPENDENT PROTEIN KINASE, CATALYTIC MECHANISM, ATP HYDROLYSIS, KEYWDS 2 TWO NUCLEOTIDE STATES, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.YANG,L.F.TEN EYCK,N.H.XUONG,S.S.TAYLOR REVDAT 6 27-OCT-21 1RDQ 1 REMARK SEQADV LINK REVDAT 5 31-JAN-18 1RDQ 1 JRNL REVDAT 4 22-JAN-14 1RDQ 1 REMARK REVDAT 3 13-JUL-11 1RDQ 1 VERSN REVDAT 2 24-FEB-09 1RDQ 1 VERSN REVDAT 1 13-APR-04 1RDQ 0 JRNL AUTH J.YANG,L.F.TEN EYCK,N.H.XUONG,S.S.TAYLOR JRNL TITL CRYSTAL STRUCTURE OF A CAMP-DEPENDENT PROTEIN KINASE MUTANT JRNL TITL 2 AT 1.26A: NEW INSIGHTS INTO THE CATALYTIC MECHANISM. JRNL REF J.MOL.BIOL. V. 336 473 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 14757059 JRNL DOI 10.1016/J.JMB.2003.11.044 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH MADHUSUDAN,P.AKAMINE,N.H.XUONG,S.S.TAYLOR REMARK 1 TITL CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE REMARK 1 TITL 2 CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE REMARK 1 REF NAT.STRUCT.BIOL. V. 9 273 2002 REMARK 1 REFN ISSN 1072-8368 REMARK 1 DOI 10.1038/NSB780 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.ZHENG,D.R.KNIGHTON,L.F.TEN EYCK,R.KARLSSON,N.H.XUONG, REMARK 1 AUTH 2 S.S.TAYLOR,SOWADSKI J.M. REMARK 1 TITL CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT REMARK 1 TITL 2 PROTEIN KINASE COMPLEXED WITH MGATP AND PEPTIDE INHIBITOR REMARK 1 REF BIOCHEMISTRY V. 32 2154 1993 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH P.AKAMINE,MADHUSUDAN,J.WU,N.H.XUONG,L.F.TEN EYCK,S.S.TAYLOR REMARK 1 TITL DYNAMIC FEATURES OF CAMP-DEPENDENT PROTEIN KINASE REVEALED REMARK 1 TITL 2 BY APOENZYME CRYSTAL STRUCTURE REMARK 1 REF J.MOL.BIOL. V. 327 159 2003 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1016/S0022-2836(02)01446-8 REMARK 2 REMARK 2 RESOLUTION. 1.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.4 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.132 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.162 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 5630 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 122674 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2891 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 79 REMARK 3 SOLVENT ATOMS : 439 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.060 REMARK 3 ANGLE DISTANCES (A) : NULL REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED CNS SOLVE 1.0, THEN SHELXL97 FOR REMARK 3 ANISOTROPIC REFINEMENT. THE R FACTOR VALUES USED FOR REFINEMENT REMARK 3 SHELL ARE ISOTROPIC B REMARK 4 REMARK 4 1RDQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-03. REMARK 100 THE DEPOSITION ID IS D_1000020669. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-01 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 114998 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.260 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05000 REMARK 200 FOR THE DATA SET : 19.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 61.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.25300 REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1APM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MPD, BICINE, AMMONIUM ACETATE, PH 8.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.88000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.86950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.75650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.86950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.88000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.75650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -42.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA E 6 REMARK 465 LYS E 7 REMARK 465 LYS E 8 REMARK 465 GLY E 9 REMARK 465 SER E 10 REMARK 465 GLU E 11 REMARK 465 GLN E 12 REMARK 465 GLU E 13 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS E 16 CG CD CE NZ REMARK 470 LYS E 21 CG CD CE NZ REMARK 470 GLU E 24 CD OE1 OE2 REMARK 470 LYS E 78 CD CE NZ REMARK 470 LYS E 81 CD CE NZ REMARK 470 LYS E 83 CE NZ REMARK 470 GLN E 176 CG CD OE1 NE2 REMARK 470 GLU E 248 CG CD OE1 OE2 REMARK 470 LYS E 254 CE NZ REMARK 470 ARG E 256 CD NE CZ NH1 NH2 REMARK 470 LYS E 285 CG CD CE NZ REMARK 470 LYS E 295 CD CE NZ REMARK 470 ILE E 315 CG1 CG2 CD1 REMARK 470 LYS E 317 CG CD CE NZ REMARK 470 PHE E 318 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS E 319 CG CD CE NZ REMARK 470 GLU E 333 CD OE1 OE2 REMARK 470 GLU E 334 CG CD OE1 OE2 REMARK 470 ASN I 520 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG E 137 CD - NE - CZ ANGL. DEV. = 13.3 DEGREES REMARK 500 ARG E 144 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG E 190 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG E 336 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA E 4 137.87 -39.22 REMARK 500 ASP E 166 49.50 -148.95 REMARK 500 ASP E 184 81.19 64.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG E 601 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN E 171 OD1 REMARK 620 2 ASP E 184 OD2 96.0 REMARK 620 3 PO4 E 598 O4 100.3 87.9 REMARK 620 4 ADP E 599 O2A 92.4 89.1 167.3 REMARK 620 5 ADP E 599 O3B 175.9 87.8 81.4 86.1 REMARK 620 6 ATP E 600 O2A 93.7 88.8 165.9 1.3 84.8 REMARK 620 7 ATP E 600 O3B 176.6 86.9 77.9 89.6 3.6 88.3 REMARK 620 8 ATP E 600 O2G 109.6 86.0 9.4 157.9 72.2 156.6 68.7 REMARK 620 9 HOH E1146 O 86.3 177.7 92.1 90.5 89.9 90.7 90.9 93.6 REMARK 620 N 1 2 3 4 5 6 7 8 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG E 602 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP E 184 OD1 REMARK 620 2 ASP E 184 OD2 59.2 REMARK 620 3 PO4 E 598 O2 148.2 89.5 REMARK 620 4 ADP E 599 O1B 90.1 87.7 94.1 REMARK 620 5 ATP E 600 O1B 88.2 87.6 96.3 2.2 REMARK 620 6 ATP E 600 O3G 153.4 94.2 7.0 89.1 91.3 REMARK 620 7 HOH E1028 O 97.3 155.6 114.4 85.5 84.7 109.1 REMARK 620 8 HOH E1029 O 85.2 92.3 91.4 174.5 172.3 96.4 92.2 REMARK 620 N 1 2 3 4 5 6 7 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 E 598 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG E 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG E 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP E 599 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP E 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD E 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL E 700 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ATP RELATED DB: PDB REMARK 900 THE WILD TYPE PROTEIN WITH SAME LIGANDS ATP AND INHIBITORY PEPTIDE DBREF 1RDQ E 1 350 UNP P05132 KAPCA_MOUSE 1 350 DBREF 1RDQ I 505 524 PDB 1RDQ 1RDQ 505 524 SEQADV 1RDQ TPO E 197 UNP P05132 THR 197 MODIFIED RESIDUE SEQADV 1RDQ ALA E 204 UNP P05132 TYR 204 ENGINEERED MUTATION SEQADV 1RDQ SEP E 338 UNP P05132 SER 338 MODIFIED RESIDUE SEQRES 1 E 350 GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN GLU SEQRES 2 E 350 SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP PHE SEQRES 3 E 350 LEU LYS LYS TRP GLU THR PRO SER GLN ASN THR ALA GLN SEQRES 4 E 350 LEU ASP GLN PHE ASP ARG ILE LYS THR LEU GLY THR GLY SEQRES 5 E 350 SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SER SEQRES 6 E 350 GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN LYS SEQRES 7 E 350 VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN GLU SEQRES 8 E 350 LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU VAL SEQRES 9 E 350 LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU TYR SEQRES 10 E 350 MET VAL MET GLU TYR VAL ALA GLY GLY GLU MET PHE SER SEQRES 11 E 350 HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS ALA SEQRES 12 E 350 ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU TYR SEQRES 13 E 350 LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS PRO SEQRES 14 E 350 GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN VAL SEQRES 15 E 350 THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG THR SEQRES 16 E 350 TRP TPO LEU CYS GLY THR PRO GLU ALA LEU ALA PRO GLU SEQRES 17 E 350 ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP TRP SEQRES 18 E 350 TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA GLY SEQRES 19 E 350 TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE TYR SEQRES 20 E 350 GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER HIS SEQRES 21 E 350 PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU LEU SEQRES 22 E 350 GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS ASN SEQRES 23 E 350 GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA THR SEQRES 24 E 350 THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU ALA SEQRES 25 E 350 PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SER SEQRES 26 E 350 ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEP SEQRES 27 E 350 ILE ASN GLU LYS CYS GLY LYS GLU PHE THR GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP MODRES 1RDQ TPO E 197 THR PHOSPHOTHREONINE MODRES 1RDQ SEP E 338 SER PHOSPHOSERINE HET TPO E 197 11 HET SEP E 338 10 HET PO4 E 598 5 HET MG E 601 1 HET MG E 602 1 HET ADP E 599 27 HET ATP E 600 31 HET MRD E 800 8 HET GOL E 700 6 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM PO4 PHOSPHATE ION HETNAM MG MAGNESIUM ION HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETNAM GOL GLYCEROL HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 TPO C4 H10 N O6 P FORMUL 1 SEP C3 H8 N O6 P FORMUL 3 PO4 O4 P 3- FORMUL 4 MG 2(MG 2+) FORMUL 6 ADP C10 H15 N5 O10 P2 FORMUL 7 ATP C10 H16 N5 O13 P3 FORMUL 8 MRD C6 H14 O2 FORMUL 9 GOL C3 H8 O3 FORMUL 10 HOH *439(H2 O) HELIX 1 1 SER E 14 THR E 32 1 19 HELIX 2 2 GLN E 39 ASP E 41 5 3 HELIX 3 3 LYS E 76 LEU E 82 1 7 HELIX 4 4 GLN E 84 GLN E 96 1 13 HELIX 5 5 GLU E 127 GLY E 136 1 10 HELIX 6 6 SER E 139 LEU E 160 1 22 HELIX 7 7 LYS E 168 GLU E 170 5 3 HELIX 8 8 THR E 201 LEU E 205 5 5 HELIX 9 9 ALA E 206 LEU E 211 1 6 HELIX 10 10 LYS E 217 GLY E 234 1 18 HELIX 11 11 GLN E 242 GLY E 253 1 12 HELIX 12 12 SER E 262 LEU E 273 1 12 HELIX 13 13 VAL E 288 ASN E 293 1 6 HELIX 14 14 HIS E 294 ALA E 298 5 5 HELIX 15 15 ASP E 301 GLN E 307 1 7 HELIX 16 16 THR I 505 ALA I 512 1 8 SHEET 1 A 5 PHE E 43 THR E 51 0 SHEET 2 A 5 ARG E 56 HIS E 62 -1 O VAL E 57 N GLY E 50 SHEET 3 A 5 HIS E 68 ASP E 75 -1 O MET E 71 N MET E 58 SHEET 4 A 5 ASN E 115 GLU E 121 -1 O MET E 118 N LYS E 72 SHEET 5 A 5 LEU E 106 LYS E 111 -1 N PHE E 110 O TYR E 117 SHEET 1 B 2 LEU E 162 ILE E 163 0 SHEET 2 B 2 LYS E 189 ARG E 190 -1 O LYS E 189 N ILE E 163 SHEET 1 C 2 LEU E 172 ILE E 174 0 SHEET 2 C 2 ILE E 180 VAL E 182 -1 O GLN E 181 N LEU E 173 SHEET 1 D 2 CYS E 199 GLY E 200 0 SHEET 2 D 2 ILE I 522 HIS I 523 -1 O ILE I 522 N GLY E 200 LINK C TRP E 196 N TPO E 197 1555 1555 1.34 LINK C TPO E 197 N LEU E 198 1555 1555 1.33 LINK C VAL E 337 N SEP E 338 1555 1555 1.31 LINK C SEP E 338 N ILE E 339 1555 1555 1.33 LINK OD1 ASN E 171 MG MG E 601 1555 1555 2.06 LINK OD2 ASP E 184 MG MG E 601 1555 1555 2.03 LINK OD1 ASP E 184 MG MG E 602 1555 1555 2.23 LINK OD2 ASP E 184 MG MG E 602 1555 1555 2.20 LINK O4 APO4 E 598 MG MG E 601 1555 1555 1.74 LINK O2 APO4 E 598 MG MG E 602 1555 1555 1.95 LINK O2AAADP E 599 MG MG E 601 1555 1555 1.97 LINK O3BAADP E 599 MG MG E 601 1555 1555 2.11 LINK O1BAADP E 599 MG MG E 602 1555 1555 2.09 LINK O2ABATP E 600 MG MG E 601 1555 1555 1.89 LINK O3BBATP E 600 MG MG E 601 1555 1555 2.31 LINK O2GBATP E 600 MG MG E 601 1555 1555 2.13 LINK O1BBATP E 600 MG MG E 602 1555 1555 2.03 LINK O3GBATP E 600 MG MG E 602 1555 1555 2.05 LINK MG MG E 601 O HOH E1146 1555 1555 2.01 LINK MG MG E 602 O HOH E1028 1555 1555 2.07 LINK MG MG E 602 O HOH E1029 1555 1555 2.10 SITE 1 AC1 13 SER E 53 PHE E 54 ASP E 166 LYS E 168 SITE 2 AC1 13 ASN E 171 ASP E 184 THR E 201 ADP E 599 SITE 3 AC1 13 MG E 601 MG E 602 HOH E1029 HOH E1146 SITE 4 AC1 13 ALA I 521 SITE 1 AC2 6 ASN E 171 ASP E 184 PO4 E 598 ADP E 599 SITE 2 AC2 6 ATP E 600 HOH E1146 SITE 1 AC3 6 ASP E 184 PO4 E 598 ADP E 599 ATP E 600 SITE 2 AC3 6 HOH E1028 HOH E1029 SITE 1 AC4 26 GLY E 50 GLY E 52 SER E 53 PHE E 54 SITE 2 AC4 26 GLY E 55 VAL E 57 ALA E 70 LYS E 72 SITE 3 AC4 26 VAL E 104 MET E 120 GLU E 121 VAL E 123 SITE 4 AC4 26 GLU E 127 GLU E 170 ASN E 171 LEU E 173 SITE 5 AC4 26 THR E 183 ASP E 184 PHE E 327 PO4 E 598 SITE 6 AC4 26 MG E 601 MG E 602 HOH E1028 HOH E1035 SITE 7 AC4 26 HOH E1146 ARG I 518 SITE 1 AC5 29 GLY E 50 GLY E 52 SER E 53 PHE E 54 SITE 2 AC5 29 GLY E 55 VAL E 57 ALA E 70 LYS E 72 SITE 3 AC5 29 VAL E 104 MET E 120 GLU E 121 VAL E 123 SITE 4 AC5 29 GLU E 127 ASP E 166 LYS E 168 GLU E 170 SITE 5 AC5 29 ASN E 171 LEU E 173 THR E 183 ASP E 184 SITE 6 AC5 29 PHE E 327 MG E 601 MG E 602 HOH E1020 SITE 7 AC5 29 HOH E1028 HOH E1029 HOH E1035 HOH E1146 SITE 8 AC5 29 ARG I 518 SITE 1 AC6 5 VAL E 15 PHE E 18 LEU E 152 GLU E 155 SITE 2 AC6 5 TYR E 306 SITE 1 AC7 8 ASP E 44 ARG E 45 PRO E 141 HOH E1147 SITE 2 AC7 8 HOH E1171 HOH E1275 HOH E1315 HOH E1408 CRYST1 57.760 79.513 97.739 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017313 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012577 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010231 0.00000 MASTER 353 0 9 16 11 0 27 6 0 0 0 29 END